Abbott’s COVID-19 tests did the heavy lifting in Q2

Abbott’s second-quarter earnings showed a mixed bag with pandemic disruptions on the medical device side of the business, and sales of COVID-19 tests driving growth for the diagnostic side.

Source: Abbott’s COVID-19 tests did the heavy lifting in Q2